Helmuth Haslacher

5.1k total citations
139 papers, 2.6k citations indexed

About

Helmuth Haslacher is a scholar working on Infectious Diseases, Hematology and Immunology. According to data from OpenAlex, Helmuth Haslacher has authored 139 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 24 papers in Hematology and 21 papers in Immunology. Recurrent topics in Helmuth Haslacher's work include SARS-CoV-2 and COVID-19 Research (23 papers), COVID-19 Clinical Research Studies (16 papers) and Platelet Disorders and Treatments (13 papers). Helmuth Haslacher is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), COVID-19 Clinical Research Studies (16 papers) and Platelet Disorders and Treatments (13 papers). Helmuth Haslacher collaborates with scholars based in Austria, United States and Germany. Helmuth Haslacher's co-authors include Thomas Perkmann, Oswald Wagner, Georg Endler, Franz Ratzinger, Georg A. Böhmig, Claudia Marsik, Farsad Eskandary, Markus Wahrmann, Patrick Mucher and Gregor Bond and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Helmuth Haslacher

128 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helmuth Haslacher Austria	26	628	467	400	399	375	139	2.6k
Willem J. van Son Netherlands	31	159 0.3×	323 0.7×	389 1.0×	703 1.8×	612 1.6×	84	2.9k
Bahar Bastani United States	29	243 0.4×	168 0.4×	144 0.4×	289 0.7×	786 2.1×	191	3.7k
Richard J. Knight United States	31	257 0.4×	367 0.8×	329 0.8×	1.0k 2.6×	988 2.6×	131	3.0k
Benjamin Wilde Germany	31	479 0.8×	218 0.5×	841 2.1×	187 0.5×	177 0.5×	117	2.5k
Marcos López‐Hoyos Spain	37	371 0.6×	333 0.7×	1.5k 3.7×	1.0k 2.6×	949 2.5×	281	5.1k
José Osmar Medina Pestana Brazil	30	329 0.5×	313 0.7×	324 0.8×	1.9k 4.7×	1.2k 3.3×	267	3.8k
David Iklé United States	35	94 0.1×	418 0.9×	576 1.4×	980 2.5×	852 2.3×	96	4.0k
Brent W. Miller United States	23	107 0.2×	292 0.6×	163 0.4×	440 1.1×	557 1.5×	42	2.3k
David N. Cornfield United States	37	162 0.3×	185 0.4×	283 0.7×	154 0.4×	800 2.1×	116	4.4k
Mark L. Jordan United States	35	225 0.4×	753 1.6×	433 1.1×	2.2k 5.6×	1.6k 4.2×	173	4.3k

Countries citing papers authored by Helmuth Haslacher

Since Specialization

Citations

This map shows the geographic impact of Helmuth Haslacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmuth Haslacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmuth Haslacher more than expected).

Fields of papers citing papers by Helmuth Haslacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmuth Haslacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmuth Haslacher. The network helps show where Helmuth Haslacher may publish in the future.

Co-authorship network of co-authors of Helmuth Haslacher

This figure shows the co-authorship network connecting the top 25 collaborators of Helmuth Haslacher. A scholar is included among the top collaborators of Helmuth Haslacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmuth Haslacher. Helmuth Haslacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simader, Elisabeth, Felix Kartnig, Selma Tobudic, et al.. (2025). Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study. BMJ Open. 15(9). e094948–e094948.

Haslacher, Helmuth, et al.. (2024). Activated protein C and free protein S in patients with mild to moderate bleeding disorders. Thrombosis Research. 235. 98–106. 1 indexed citations

Tobudic, Selma, Elisabeth Simader, Felix Kartnig, et al.. (2023). The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination. Frontiers in Medicine. 10. 1049157–1049157. 5 indexed citations

Thalhammer, Renate, et al.. (2023). Evaluation of the Sysmex DI‐60 digital morphology analyzer on Wright‐stained samples with a focus on prevalence‐dependent quality indicators. International Journal of Laboratory Hematology. 46(1). 83–91.

Mair, Maximilian J., Rainer Puhr, Marlene Troch, et al.. (2023). Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. Infectious Agents and Cancer. 18(1). 9–9. 1 indexed citations

Kerschan‐Schindl, Katharina, Peter Dovjak, B Mayr, et al.. (2023). Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover. Journal of Bone and Mineral Research. 38(7). 943–950. 13 indexed citations

Aigner, Christof, Patrick Mucher, Helga Schachner, et al.. (2023). Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma. SHILAP Revista de lepidopterología. 2(5). e88–e88. 10 indexed citations

Jomrich, Gerd, Elisabeth S. Gruber, Jakob Mühlbacher, et al.. (2023). Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment. Journal of Visceral Surgery. 161(2). 99–105. 1 indexed citations

Mucher, Patrick, P Schmidt, Astrid Radakovics, et al.. (2022). Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability. Clinical Chemistry and Laboratory Medicine (CCLM). 60(5). 701–706. 10 indexed citations

10.

Perkmann, Thomas, Patrick Mucher, Rodrig Marculescu, et al.. (2022). Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant. Microbiology Spectrum. 10(5). e0212922–e0212922. 19 indexed citations

11.

Schosser, Alexandra, Birgit Ludwig, Laura Carlberg, et al.. (2022). BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression. European Neuropsychopharmacology. 58. 103–108. 4 indexed citations

12.

Koblischke, Maximilian, Lisa Schneider, Edit Porpaczy, et al.. (2022). Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers. 14(8). 1962–1962. 7 indexed citations

13.

Tolios, Alexander, Stefanie Hofer, Cihan Ay, et al.. (2021). Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency. Blood Advances. 5(2). 391–398. 20 indexed citations

14.

Arfsten, Henrike, Georg Goliasch, Philipp E. Bartko, et al.. (2021). Neprilysin Inhibition does not Alter Dynamic of Proenkephalin-A 119-159 and Pro-Substance P in Heart Failure. ESC Heart Failure. 8(3). 2016–2024. 3 indexed citations

15.

Perkmann, Thomas, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.. (2020). Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity. Clinical Chemistry. 66(11). 1405–1413. 80 indexed citations

16.

Hofer, Stefanie, Christof Jungbauer, Alexandra Kaider, et al.. (2020). Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. Blood Advances. 4(20). 5157–5164. 32 indexed citations

17.

Haslacher, Helmuth, Marlene C. Gerner, Philipp Hofer, et al.. (2018). Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank. Biopreservation and Biobanking. 16(6). 477–482. 63 indexed citations

18.

Schmidt, Ralf, Alexander Simon, Theresia Popow‐Kraupp, et al.. (2018). A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection. Clinical Microbiology and Infection. 25(8). 1032–1037. 12 indexed citations

19.

Eskandary, Farsad, Gregor Bond, Heinz Regele, et al.. (2014). Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial.. PubMed. 189–95. 9 indexed citations

20.

Winker, Robert, Thomas Perkmann, Helmuth Haslacher, et al.. (2010). Cognitive function in elderly marathon runners: Cross-sectional data from the marathon trial (apsoem). Wiener klinische Wochenschrift. 122(23-24). 704–716. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact